CURRENT OPINION IN OBSTETRICS & GYNECOLOGY妇产科学当前观点
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY(英文缩写 CURR OPIN OBSTET GYN),ISSN 1040-872X,eISSN 1473-656X,中文译名:妇产科学当前观点 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-27 至 2026-09-27，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 2.211 | Q4 |
| 2022 | 2.100 | Q3 |
| 2023 | 2.200 | Q2 |
| 2024 | 2.100 | Q2 |
| 2025 | 2.400 | Q2 |
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY 最新收录文献
-
1. Postmenopausal endometriosis: current evidence and clinical challenges in diagnosis and treatment.
PMID:日期:2026-10-01Endometriosis was once thought to affect only reproductive-aged women. However, 2-5% of postmenopausal individuals remain affected. Guidance for this group is limited. This review outlines an updated approach to postmenopausal endometriosis, addressing pathophysiology, diagnostic challenges, and management in both natural and surgical menopause. Postmenopausal endometriosis is underrecognized and has many diagnostic challenges. MRI is the preferred imaging modality for detecting lesions and assessing malignancy risk, while surgery with excision remains the diagnostic and treatment gold standard. Medical treatment options are limited, with aromatase inhibitors showing the most promise by targeting main sources of estrogen production; however, research is limited. Hormonal replacement therapy is recommended after surgical or premature menopause (<age 45), and hormone therapy may be considered for symptomatic natural menopause, though optimal regimens and duration remain unclear. Combined estrogen-progestogen therapy or tibolone is preferred due to the possible risk of recurrence or malignancy. Ovarian-sparing surgery may be considered in select younger patients to reduce the need for hormonal replacement therapy given the lack of data. Evidence on postmenopausal endometriosis remains limited. Further research is needed to guide treatment, refine hormone therapy strategies, and improve long-term outcomes and quality of life.
-
2. The evolution of women's health toward personalized, patient-centered care.
PMID:日期:2026-10-01该文献暂无摘要。
-
3. Advocacy around abortion in a politically charged climate.
3. 在政治敏感环境下的堕胎倡导PMID:日期:2026-10-01To examine the evolving role of clinician advocacy in abortion care and to highlight key domains through which obstetrician-gynecologists can influence policy, clinical practice, and patient outcomes. Increasing state-level abortion restrictions have significantly altered the landscape of reproductive healthcare in the USA. Emerging evidence demonstrates worsening barriers to care, delays in treatment, and increased morbidity, particularly for marginalized populations. Clinicians are responding through a range of advocacy strategies, including interpersonal communication, institutional policy development, engagement with professional societies, and the use of research to inform policy. Community-engaged research and near real-time data initiatives have been especially valuable in documenting the impacts of legal changes and amplifying patient-centered perspectives. In the post- Dobbs era, advocacy continues to be an integral component of obstetric and gynecologic practice. Multilevel engagement - from clinical interactions to institutional and policy reform - is essential to mitigating harm and promoting equitable access to evidence-based care. Strengthening clinician advocacy, particularly in partnership with affected communities, will be critical to addressing disparities and shaping a more equitable reproductive healthcare system.
-
4. Management of menopausal hormone therapy.
PMID:日期:2026-10-01The purpose of this review is to provide practical guidance on managing menopausal hormone therapy (MHT) and to provide updated guidance on the risks and benefits of MHT. Reanalysis of the Women's Health Initiative and recent studies have demonstrated the protective role of estrogen in cardiovascular disease (CVD) and bone health, particularly when initiated before the age of 60. There is an increased risk of venous thromboembolism (VTE) with oral formulations, but formulations using transdermal estradiol and micronized progesterone do not appear to increase VTE risk. MHT may be helpful in perimenopausal and menopausal mood disorders. The timing hypothesis may be applicable to both CVD and cognition. Management of symptomatic menopause requires personalized risk assessment and shared decision-making with a knowledgeable provider. For otherwise healthy women less than 60 years old or within 10 years of menopause, hormone therapy is a safe and effective treatment for vasomotor symptoms. Although the role of MHT is being studied for various preventive strategies, major medical societies do not yet recommend MHT for primary prevention.
-
5. Pain control options for intrauterine device placement and endometrial biopsy.
5. 宫内节育器放置和子宫内膜活检的疼痛控制选择PMID:日期:2026-10-01To review the effectiveness of pain control methods for outpatient intrauterine device (IUD) insertions and endometrial biopsy (EMB) procedures. Several approaches to decreasing pain with ambulatory IUD placement and EMB have been evaluated in the literature. Paracervical blocks, cervical lidocaine spray, nonsteroidal anti-inflammatory drugs (NSAIDs), and anxiety reduction techniques have been shown to decrease pain reported by patients. For both IUD insertion and EMB, evidence regarding NSAIDs for intraprocedural pain is mixed, and they should be advised to decrease postprocedural cramping. A paracervical block with local anesthesia successfully targets pain but can cause discomfort with injection. Misoprostol may improve ease of IUD insertion and thus may be useful in select patients with difficult placements; however, routine use is not recommended because of increased side effects and risk of expulsion. Ultrasound-guided IUD insertion and nitrous oxide administration have also shown efficacy but are limited by cost and logistical barriers. Pain during IUD placement and EMB is multifactorial and best addressed with use of an individualized, multimodal approach. Shared decision-making should guide clinician and patient discussion for offering strategies such as preprocedural NSAIDs, lidocaine spray, paracervical blocks, and anxiety management to all patients to optimize comfort and procedural experience.
-
6. Obstetric management and counseling for threatened periviable birth.
PMID:日期:2026-10-01Improving survival rates for extremely preterm infants have shifted the threshold for postnatal intervention earlier, although outcomes remain uncertain. Counseling for families facing periviable birth is complex, requiring integration of evolving data, ethical considerations, and patient values. Obstetricians play a key role in this counseling. This review synthesizes recent evidence on obstetric interventions at periviability, alongside best practices for counseling. Emerging data demonstrate improving survival at 22-23 weeks, although outcomes vary, highlighting the importance of using up-to-date, institution-specific outcomes in counseling. Obstetric management, including antenatal corticosteroids and mode of delivery, plays a critical role in influencing neonatal outcomes and should be integrated into counseling. Shared decision-making remains central but is challenged by prognostic uncertainty and differing values. In addition, counseling is further shaped by tone, language, and framing of the data presented. Structured counseling tools and multidisciplinary approaches may improve consistency and comprehension but remain underutilized. Periviability care requires integration of evidence-based obstetric management with patient-centered counseling. A multidisciplinary, emotionally attuned approach is essential to support shared, value-concordant decisions. Future efforts should focus on optimizing counseling frameworks and expanding the use of decision support tools while preserving individualized care.
-
7. Evaluation of vaginitis and its treatment.
PMID:日期:2026-10-01Vaginitis is one of the most common reasons a patient will present for care in both the ambulatory and urgent care settings. The objective of this review is to summarize traditional methods of evaluation and treatment for the most commonly seen vaginitis and vaginosis, but also to present updated literature and future management directions for this common and sometimes resilient medical problem. A randomized controlled trial of partners in monogamous heterosexual relationships and the recurrence rate of bacterial vaginosis when male partners were simultaneously treated. Systematic review investigating the effectiveness of intravaginal vitamin C in treating and preventing recurrent bacterial vaginosis. Randomized controlled trial evaluating oteseconazole and its benefit against recurrent vulvovaginal candidiasis. A meta-analysis to evaluate breast cancer recurrence and mortality among breast cancer survivors using vaginal estrogen for genitourinary syndrome of menopause. Vaginitis is an incredibly common problem among women of all ages globally. Traditional therapies, including oral and topical antibiotics and antifungals, are effective in many patients, but recurrence is common, necessitating prolonged suppressive therapy. Newer therapies include partner treatment, but also the use of newer medications with different mechanisms of action and consideration of adjunctive therapies such as vaginal pH-modulating topicals and adjunctive live biotherapeutic products.
-
8. What obgyns need to know about GLP-1 receptor agonists.
PMID:日期:2026-10-01Obstetricians and gynecologists increasingly encounter patients using glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists. This review synthesizes evidence on these agents, focusing on their relevance in women's health. GLP-1 receptor agonists and dual agonists achieve 15-21% body weight reduction in phase 3 trials, with tirzepatide demonstrating superior efficacy compared to semaglutide. Key populations of interest include patients with polycystic ovary syndrome (PCOS), pregnant patients, and those undergoing gynecologic surgery. In women with PCOS, meta-analyses confirm improvements in insulin resistance, androgen levels, and ovulation rates. Tirzepatide significantly delays gastric emptying, prompting manufacturer guidance to use backup contraception for 4 weeks after initiation or dose escalation. Emerging human cohort studies of inadvertent early pregnancy exposure report no increased risk of major congenital malformations, providing preliminary reassurance despite animal teratogenicity data. Perioperative guidance has evolved from blanket discontinuation to individualized, risk-stratified approaches. GLP-1 receptor agonists offer benefits across the lifespan, with promising applications in PCOS and preconception optimization. Reproductive-aged women need counseling regarding contraception and preconception discontinuation. Knowledge gaps include the need for pregnancy registries. Obstetrician-gynecologists will increasingly encounter these therapies and must navigate evolving evidence regarding their safety, efficacy, and clinical implications.
-
9. Essential papers in women's mental health: an educational resource for physicians and trainees.
PMID:日期:2026-10-01This article provides a high-yield, educational resource on Women's Mental Health (WMH). By facilitating access to specialized psychiatric knowledge in a concise format, this annotated bibliography facilitates the widespread dissemination and uptake of essential WMH literature, supports medical training, and contributes to the delivery of evidence-based care. There is increasing recognition that medical providers must be prepared to identify and address the mental health needs of women during the perinatal period and throughout the reproductive lifespan. Despite this, there is a notable lack of formal WMH-related education in medical training. The WMH Special Interest Group of the Academy of Consultation-Liaison Psychiatry convened a workgroup to identify foundational WMH literature. Using expert nominations and a structured survey, 40 articles across 15 categories were evaluated for clinical importance and quality of scholarship. Five domains emerged as most relevant for trainee education: postpartum psychosis, risk-benefit decision-making, psychotropic use in pregnancy and lactation, perinatal mood and anxiety disorders, and substance use in pregnancy. Ten articles were identified as having the highest impact, with five additional articles included, reflecting the breadth of critical scholarship in the field. Clinical pearls were systematically developed and reviewed for consistency.
-
10. More than a pinch: a review of pain management during intrauterine device placement.
PMID:日期:2026-09-24Pain during intrauterine device (IUD) insertion is currently a major focus of contraceptive care, driven by patient advocacy, social media discourse, and growing recognition that procedural pain may deter patients from seeking an IUD. Concurrently, professional organizations have released updated guidance on pain management during IUD placement. This review summarizes contemporary evidence regarding patient risk factors, procedural techniques, and pharmacologic and non-pharmacologic interventions for IUD insertion pain. Recent literature demonstrates that pain during IUD placement is multifactorial and influenced by patient characteristics, including nulliparity, dysmenorrhea, anxiety, and anticipated pain. Among available interventions, the strongest evidence supports local anesthetic approaches. Ultrasound-guided placement may reduce pain and procedural difficulty. In contrast, routine use of misoprostol is not supported by current evidence. Data regarding non-pharmacologic environmental interventions, oral anxiolytics/opiates, nitrous oxide, intravenous sedation, and operating room-based anesthesia care remain limited or conflicting. Effective pain management for IUD placement likely requires a multimodal, patient-centered approach that addresses both physiologic and psychological contributors to pain. Future research should prioritize standardized outcome measures, comparative effectiveness studies, and implementation and cost-effectiveness analyses to inform equitable integration of evidence-based pain management strategies for IUD insertions.